Background/Aims: Older people undergoing surgery are at risk of developing postoperative cognitive dysfunction (POCD), but little is known of risk factors predisposing patients to POCD. Our objective was to estimate the risk of POCD associated with exposure to preoperative diabetes, hypertension, and obesity. Methods: Original data from 3 randomised controlled trials (OCTOPUS, DECS, SuDoCo) were obtained for secondary analysis on diabetes, hypertension, baseline blood pressure, obesity (BMI ≥30 kg/m 2 ), and BMI as risk factors for POCD in multiple logistic regression models. Risk estimates were pooled across the 3 studies. Results: Analyses totalled 1,034 patients. POCD occurred in 5.2% of patients in DECS, in 9.4% in SuDoCo, and in 32.1% of patients in OCTOPUS. After adjustment for age, sex, surgery type, randomisation, obesity, and hypertension, diabetes was associated with a 1.84-fold increased risk of POCD (OR 1.84; 95% CI 1.14, 2.97; p = 0.01). Obesity, BMI, hypertension, and baseline blood pressure were each not associated with POCD in fully adjusted models (all p > 0.05). Conclusion: Diabetes, but not obesity or hypertension, is associated with increased POCD risk. Consideration of diabetes status may be helpful for risk assessment of surgical patients.
Introduction
Patients undergoing surgery are at risk of developing a postoperative neurocognitive disorder or postoperative cognitive dysfunction (POCD) -a condition that is defined by a decline in performance on neuropsychological tests from pre-surgery to post-surgery assessment. Large individual differences in POCD spanning cognitive recovery during the first few months to persistent cognitive impairment have been reported [1] [2] [3] [4] [5] . Although it has been the subject of extensive research during the past two decades, many questions remain unanswered, and a lack of uniform diagnostic criteria [6] and differences in length of follow-up period hamper comparability between studies. Little is currently known about potential risk factors, which help to identify at-risk patients and shed light on underlying pathophysiology. In recent systematic reviews and meta-analyses [7] [8] [9] [10] , we have shown that patients with metabolic derangement may be at an increased risk of POCD. Indicators of metabolic derangement include classical vascular risk factors such as elevated blood glucose, elevated blood pressure, and obesity, which all tend to correlate [11] . In line with its well-established role as a predictor of age-related cognitive impairment [12] [13] [14] [15] [16] , we found in our meta-analysis that diabetes was associated with a 26% increased risk of POCD [8] . Findings were less clear for obesity [17] , and hypertension was overall not associated with POCD [10] . However, studies included in those meta-analyses were largely exploratory and frequently failed to apply statistical adjustment for potential confounders, which is considered a major limitation. Detailed assessment of exposure to these candidate risk factors and subsequent risk of POCD on the basis of primary data is thus needed, particularly in view of their modifiable nature that leaves scope for risk alteration at individual patient level.
Here, we therefore aimed to estimate the risk of POCD associated with preoperative exposure to diabetes, hypertension, and obesity, with focus on potential mutual confounding among the risk factors in determining POCD risk. Data were provided by 3 large randomised controlled trials (RCTs) targeting factors and procedures potentially influencing POCD risk. In a secondary analysis of their primary data, we evaluated risk of POCD associated with each exposure of interest and additionally provide pooled risk estimates combined across the 3 studies.
Materials and Methods

Study Design
In a quasi-observational, secondary analysis of 3 studies, the Surgery Depth of Anaesthesia Cognitive Outcome (SuDoCo) [18] , Dexamethasone for Cardiac Surgery (DECS) [19, 20] , and OCTOPUS [21] studies, associations of exposure to diabetes, hypertension, and obesity with POCD risk were determined. None of the 3 studies had previously been used to investigate this research question. Access to their original data resulted from a cross-institutional collaboration.
Physical Examination
Diabetes and a history of hypertension were routinely ascertained during pre-surgery interview and from medical records. Though we were unable to distinguish between type 1 and type 2 diabetes based on the data, we assume that a majority of patients with diabetes will have suffered from type 2 diabetes based on sample age. Baseline blood pressure, height, and weight were measured at pre-surgery assessment, and height and weight were used to derive body mass index (BMI). In accordance with convention [22] , we . A conservative cut-point of BMI < 20 kg/m 2 identified underweight patients.
Cognitive Examination and Definition of POCD
Trained staff administered several age-sensitive neuropsychological tests tapping various cognitive domains (OCTOPUS: n = 11 tests; DECS: n = 5 tests; SuDoCo: n = 6 tests; online suppl. Table 1 ; for all online suppl. material, see www.karger.com/doi/10.1159/000492962) to the respective patient samples and additionally to non-surgical control samples for normative data. For the purpose of this analysis, we used POCD as dichotomous outcome as it was defined in the respective original studies. This varied between studies. For DECS and SuDoCo, POCD was defined through comparison of the cognitive change of patients with the average cognitive change of the respective control group; for OCTOPUS, POCD was determined from raw change in cognitive test scores (online suppl. Table 1 ).
Statistical Methods
Exposures of interest were the presence versus absence of diabetes, hypertension, and obesity, respectively. In addition, we also analysed BMI and systolic and diastolic baseline blood pressure. Outcome was POCD at the longest follow-up assessment in each cohort. A two-step approach was used to analyse exposureoutcome relationships [23, 24] . Initially, risk of POCD according to exposure to diabetes, hypertension, obesity, BMI, systolic blood pressure, and diastolic blood pressure was assessed separately for each of the 3 studies. We used logistic regression analyses with hierarchical model building: model 0 includes unadjusted associations, model 1 includes age and sex as covariates, model 2 additionally includes type of surgery and RCT treatment group, and model 3 additionally includes all of the respective remaining predictor variables (of diabetes, obesity, hypertension) to analyse potential mutual confounding. Baseline blood pressure and BMI were not included as covariates in model 3 to avoid collinearity as these variables contributed to the definition of "hypertension" and "obesity," respectively. For OCTOPUS and DECS, we also adjusted for education in models 2 and 3 but present data without that adjustment to allow cross-study comparison, as in SuDoCo, information on education was not available. Odds ratios (OR) are provided for 1-point increments in BMI and 10-point increments in baseline blood pressure values to aid interpretability of risk estimates.
In a second step, risk estimates were pooled across all 3 studies (total patients n = 1,034) for each exposure variable and for each of the statistical modelling steps using fixed-effects inverse variance analyses. This approach to combining data was selected on the basis that one true underlying effect was assumed to underlie all 3 studies [25] and weighs studies according to the standard error of their estimates (i.e., studies with lower standard error are given greater weight). The respective final models (Model 3) were repeated post hoc using random-effects models to show the mean distribution of effects [25] . The results of these analyses are shown as Supplemental Data (online suppl. Table 2 ). Statistical heterogeneity between studies was assessed using the I 2 index [26] .
Analyses were repeated post hoc with exclusion of underweight patients to ensure that findings were not driven by underweight which is a well-established risk factor for age-related cognitive impairment [27] and may also be associated with POCD. Analyses were performed with IBM © SPSS © Statistics (version 23) and Review Manager (version 5.3). The statistical analysis plan was approved by an internal committee before any of the analyses were performed.
Results
Study Characteristics
Characteristics of the patient samples completing follow-up of the 3 studies are shown in Table 1 Data are presented as mean ± SD or n (%). BIS, bispectral index; SBP, systolic blood pressure; DBP, diastolic blood pressure. All data measured before surgery and shown for respective follow-up sample. For each study, loss to follow-up mainly due to non-response or change in intention of patients. Data on diabetes missing for 1 patient and on obesity for 2 patients in DECS. a Data not available for all cohorts. 34 .1 kg/m 2 (SD = 4.1), respectively. Systolic and diastolic blood pressure correlated positively with one another in the 2 studies that measured blood pressure (r = 0.49-0.57; both p < 0.001), whereas neither was associated with BMI in those studies (all p > 0.10).
Associations of Diabetes, Hypertension, and Obesity with Risk of POCD POCD occurred in 12 patients (5.2%) at 12-month follow-up in DECS. Of these, 4 had diabetes (33.3%), 4 were obese (33.3%), and 8 had hypertension (66.7%). In SuDoCo, POCD occurred in 52 patients (9.4%) at 3 months. Sixteen (30.8%) of those 52 patients had diabetes, 12 (23.1%) were obese and 38 (73.1%) had hypertension. Eighty-one patients (32.1%) in OCTOPUS had POCD at 12 months, of whom 15 (18.5%) had diabetes, 13 (16.0%) were obese, and 40 (49.4%) had hypertension. In the pooled analysis, after adjustment for age, sex, type of surgery and randomisation, diabetes was associated with a 1.97-fold (95% CI 1.24-2.97) higher risk of POCD, while hypertension was associated with a 1.50-fold (95% CI 1.01-2.24) higher risk ( Table 2 ; Fig. 2 ). In contrast, obesity was not significantly associated with risk of POCD (OR 1.22; 95% CI 0.76-1.96). Risk estimates were similar when random-effects models were used (online suppl. Table 2 ), when underweight patients were excluded from analysis (data not shown) and also remained unchanged after additional adjustment for education in the 2 studies with education data (OCTOPUS; DECS; data not shown). After additional adjustment for hypertension and obesity, diabetes remained significantly associated with a higher risk of POCD, with a pooled OR of 1.84 (95% CI 1.14-2.97; Model 3 in Table 2 calculated from OCTOPUS, OR 1.90, 95% CI 0.86-4.21; DECS, OR 2.94, 95% CI 0.69-12.52; SuDoCo, OR 1.62, 95% CI 0.84-3.15) and no evidence of statistical heterogeneity between studies (χ 2 = 0.55; p = 0.76; I 2 = 0%). In contrast, hypertension was not significantly associated with risk of POCD after additional adjustment for diabetes and obesity (OR 1.37; 95% CI 0.91-2.07). Similar to the results reported above, obesity was not significantly associated with POCD in these fully adjusted models.
Associations of BMI and Systolic and Diastolic Baseline Blood Pressure with POCD
BMI was not significantly associated with risk of POCD (online suppl. Table 3 ; Fig. 3 ) in the analysis pooled across the 3 studies. Again, these results were not substantially different when random-effects models were used (online suppl. Table 2 ) or when underweight patients were excluded from the analysis (data not shown). Neither systolic nor diastolic baseline blood pressure was significantly associated with POCD risk, although this analysis was restricted to 2 studies (online suppl. Table 3) .
Discussion
Across 3 studies, we found evidence that diabetes was associated with a 1.84-fold higher risk of POCD. Importantly, the association was independent of age, sex, type of surgery, and intervention, as well as obesity and hypertension. Hypertension and obesity were not independently associated with risk of POCD. These findings extend our previous meta-analyses which, largely based on unadjusted results of exploratory studies, had found significant associations for diabetes but not for obesity or hypertension with POCD risk [7, 8, 10] .
The pathophysiology of developing POCD is poorly understood. Neuroinflammation with subsequent microglial overactivation and disruption of the blood brain barrier is assumed to play a role in the development of short-term postoperative cognitive impairment [28] . Other theories on causes of POCD include impaired cerebral perfusion during surgery [29] , lasting neurotoxic effects of anaesthetics, as well as detrimental effects of perioperative opioid use on brain function [30, 31] . Environmental factors such as hospital environments and sleep disturbances, too, may play a role [31] . However, these theories cannot easily explain the higher POCD risk in patients with diabetes. Patients with diabetes generally show greater cerebral and hippocampal atrophy [32] [33] [34] , cerebral microvascular [35, 36] and macrovascular damage [37] , and are also at increased risk of cognitive impairment [15, 38, 39] compared with non-diabetics. Similar observations have been made for hyperglycaemia short of diabetes diagnosis [40, 41] and poorer glycaemic control in patients with diabetes [42] , which indicates fundamental influences of impaired glucose metabolism on the brain. It appears that the negative impact of hyperglycaemia on brain function may be accelerated due to surgery as it was observed for patients with diabetes during relatively short follow-up periods of 3-12 months in the present analysis. Further, our findings suggest somewhat higher odds of POCD in the 2 studies with cardiac patients (DECS; OCTOPUS) compared with the study of noncardiac patients (SuDoCo), which reiterates a statistically non-significant trend in the same direction in our meta-analysis [8] . This warrants further evaluation. It may be that negative impacts of diabetes on the vasculature increase POCD risk following vascular interventions. Though we cannot determine causality on the basis of the present epidemiological findings, our results may reflect neurotoxic effects of persistently high blood glucose that ultimately impairs neurons with subsequent loss of function [43] . Surgery-associated high grade systemic inflammation [44] may have affected previously damaged neurons in patients with diabetes resulting in POCD. Further studies are thus needed to add to our understanding of the pathophysiology of surgical brain damage in the context of hyperglycaemia and diabetes. An influence of type of anti-diabetic treatment and glycaemic control including prior history of hypoglycaemia which itself seems to increase cognitive risk [45, 46] should additionally be considered in further observational studies that collect more detailed data, for instance on HbA1c levels, duration of diabetes, and treatment type, of their patients with diabetes, and trial studies may also be possible. An influence of improved glycaemic control during the weeks before surgery on POCD risk could be assessed in a sample of people with type 2 diabetes, for example. Hypertension is a major influencing factor for cardiovascular events such as stroke and myocardial infarction due to vascular damage [47] . However, we did not see any significant influence of a prior history of hypertension on risk of POCD that was independent of its link to diabetes. The null finding suggests that vascular damage as a consequence of hypertension may only play a minor role in POCD development and replicates results of our meta-analysis of hypertension as a candidate risk factor for POCD [10] . Though we did not assess severity of hypertension which may be important in cognitive risk prediction [48] , our finding warrants further enquiry particularly in view of established associations of this risk factor with cognitive impairment per se [15, 49, 50] . A beneficial effect of anti-hypertensive treatment on cognitive risk as an explanation of the null finding appears unlikely as the balance of evidence from RCTs speaks against such effects [51, 52] . Obesity is a pro-inflammatory state characterised by raised circulating inflammatory markers [53, 54] , which itself appears to promote cognitive dysfunction after surgery [55] . We therefore hypothesised that obesity may be a risk factor for POCD. The results of the present analysis and of our previous meta-analysis [7] do not appear to support this hypothesis. Indeed, when looking to age-related cognitive impairment, increasing evidence suggests that while midlife obesity appears to increase risk of later impairment, obesity in later life does not. For instance, a recent analysis of the Whitehall II study of > 10,000 individuals in the UK found obesity at age 50 but not at age 60 or 70 predicted dementia risk [56] . Some studies even corroborate an "obesity paradox" with beneficial effects of obesity on cognitive function in later life [57] which may reflect effects of prodromal stages of dementia on body weight [56, 58] . We have no information on body weight status at midlife or weight trajectories of participants but suspect that similar processes may underlie the lack of an association of obesity and POCD risk in the present analysis. We also cannot rule out potential harmful effects of obesity that we may have missed due to lack of statistical power.
Strengths of our study include the use of primary data from 3 studies on POCD that allowed adjustment for a range of potential confounders. By entering all 3 exposures of interest into the same statistical models, our approach further allowed determination of the relative contribution of diabetes, obesity, and hypertension to POCD risk. Sensitivity analyses were able to show that the absence of an association of obesity or BMI with POCD risk was not driven by inclusion of underweight patients in the main analyses.
A number of limitations must be considered. We followed a two-step approach to data analysis and pooling of estimates rather than individual-patient meta-analysis. Readers should also be aware that we assessed 3 exposures for associations with POCD, which may have increased type I statistical error. However, findings on diabetes and POCD risk remained unchanged with Bonferroni correction of the critical p value indicative of statistical significance. Importantly, different psychological batteries for determining POCD were used in each of the 3 studies. This could have influenced POCD incidence, which was particularly low for DECS and thus may have limited our statistical modelling that included a number of covariates. Prevalence of diabetes and hypertension varied between the 3 studies, and likely reflected a difference in health status between samples. Generalisability of our findings is therefore unclear. As cognitive deficits often appear to resolve over time [3, 4, 59] , the pooling of effects across studies with 3-to 12-month follow-up periods was suboptimal and will have led to incidence of POCD ranging from 5.2 to 32.1%. Cohort effects were introduced by recruitment periods spanning from 1998 to 2011, and our findings may not necessarily apply to patients undergoing surgery today. Further, the studies had not set out to investigate the present exposures of interest and risk of POCD. Thus, assessment of diabetes, hypertension, and obesity may not have been consistently rigorous, and we were not able to discriminate between type 1 and type 2 diabetes. An influence of other well-established risk factors for POCD, such as previous cerebrovascular event known to be associated with diabetes [60] as well as POCD [1] , on our findings is also plausible. We deem an influence of pre-existing cognitive impairment which, too, is associated both with diabetes [14] and POCD [8] unlikely as SuDoCo, which was weighted most heavily in the combined analyses, excluded patients with baseline cognitive impairment. Between-study differences in assessment of other factors such as blood loss during surgery meant that adjustment was not possible for all potential confounders. Residual confounding is therefore possible. Various definitions of POCD were used. In DECS and SuDoCo, POCD was defined relative to cognitive change of non-surgical control groups, and neither had information available on prevalence of diabetes, hypertension and obesity in the control subjects. Thus, we cannot determine whether the present findings reflect associations of diabetes with POCD versus associations with cognitive decline per se. This also applies to the OCTOPUS study which defined POCD from raw cognitive change. Here, patients with diabetes (even if not exposed to surgery) may have simply declined at steeper rates during follow-up compared with non-diabetics. OCTOPUS also reported an incidence rate of POCD of around one-third of patients at 12-month follow-up, which is high relative to previous studies [61] . Post-surgery stroke was considered as "POCD" in OCTOPUS and DECS, which complicates the interpretation of findings on POCD as a form of impairment as opposed to overt cerebrovascular disease. Further, any non-linear associations of BMI with POCD risk were presumably not well captured by a single cut-off at BMI ≥30 kg/m 2 for definition of obesity. However, when we excluded underweight patients and those with postoperative stroke from analyses, findings remained unchanged.
In conclusion, our results suggest that people with diabetes are at increased risk of POCD and independently of co-morbid obesity or hypertension. Consideration of diabetes status may thus be helpful for assessment of POCD risk to help clinicians and patients alike to make informed decisions when electing surgery. Enhanced post-surgery care for patients with diabetes that includes screening for POCD may also be indicated.
